← Back to patent-cliff list
CAS 431-47-0
methyl 2,2,2-trifluoroacetate
Codes：EFAV-022
Application context (from source-drug indications)
HIV感染依非韦伦/拉米夫定/富马酸替诺福韦二吡呋酯
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 依非韦伦/拉米夫定/富马酸替诺福韦二吡呋酯Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethynylcyclopropane→1,4-dichlorobenzene→methyl 2,2,2-trifluoroacetate→1-(2,5-dichlorophenyl)-2,2,2-trifluoroethanone→(R)-N-(1-hydroxy-1,1-diphenylpropan-2-yl)naphthalene-2-sulfonamide→(S)-4-cyclopropyl-2-(2,5-dichlorophenyl)-1,1,1-trifluorobut-3-yn-2-ol→(S)-4-cyclopropyl-2-(2,5-dichlorophenyl)-1,1,1-trifluorobut-3-yn-2-yl carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.